Press release on Premas – IncellDx Sign Distribution Agreement

It follows the successful study at AIIMS Institute utilising IncellDx’s (3Dx) investigational molecular assay

Premas Life Sciences and IncellDx have signed an exclusive distribution agreement. Included in the deal are IncellDx’s patented single-cell assays for quantifying PD-L1 on tumour cells and immune cell subtypes; patented single-cell assay for HPV E6/E7 mRNA detection in cervical samples; and, its incellPREP single-cell preparation kit for solid tissues including tumours.

It follows a study done by researchers at AIIMS, New Delhi who have completed a successful study utilising IncellDx’s (3Dx) investigational molecular assay which quantifies E6, E7 mRNA overexpression in single cells simultaneously with the measurement of cell cycle and cell proliferation, the hallmark of progressive disease.

Article Link: Pharma Biz